19th week of 2020 patent applcation highlights part 10 |
Patent application number | Title | Published |
20200138843 | COMPOSITIONS FOR TREATING PAIN AND INFLAMMATION | 2020-05-07 |
20200138844 | PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF | 2020-05-07 |
20200138845 | Combination Drug Therapy | 2020-05-07 |
20200138846 | ENZYMATIC REPLACEMENT THERAPY AND ANTISENSE THERAPY FOR POMPE DISEASE | 2020-05-07 |
20200138847 | MYOSTATIN IRNA COMPOSITIONS AND METHODS OF USE THEREOF | 2020-05-07 |
20200138848 | IMMUNE MODULATION WITH TLR9 AGONISTS FOR CANCER TREATMENT | 2020-05-07 |
20200138849 | REAGENTS FOR TREATMENT OF OCULOPHARYNGEAL MUSCULAR DYSTROPHY (OPMD) AND USE THEREOF | 2020-05-07 |
20200138850 | COMPOSITION AND METHOD FOR PROMOTING REDUCTION OF HEAT STRESS IN ANIMALS | 2020-05-07 |
20200138851 | FILM FOR TOPICAL APPLICATION IN THE TREATMENT OF SKIN LESIONS AND METHOD OF OBTAINING AND APPLYING SAME | 2020-05-07 |
20200138852 | METHODS AND SYSTEMS FOR INHIBITING FOREIGN-BODY RESPONSES IN DIABETIC PATIENTS | 2020-05-07 |
20200138853 | OPHTHALMIC COMPOSITIONS WITH IMPROVED DESSICATION PROTECTION AND RETENTION | 2020-05-07 |
20200138854 | Method of Detecting and Quantifying Bile Acid from Saliva | 2020-05-07 |
20200138855 | NOVEL ANTINEOPLASTIC DRUG BASED ON SPECIFICITY OF CANCER-CELL METABOLISM | 2020-05-07 |
20200138856 | PERIPHERAL NEUROPATHY COMPOSITION AND RELATED METHODS | 2020-05-07 |
20200138857 | VANADIUM INSULIN-MIMETICS, METHODS OF PREPARATION, AND METHODS FOR TREATMENT OF DIABETES | 2020-05-07 |
20200138858 | SILVER OXIDE FORMULATIONS | 2020-05-07 |
20200138859 | HAR-NDS-DERIVED STEM CELLS, METHOD FOR SEPARATING SAME, AND USE THEREOF | 2020-05-07 |
20200138860 | BLOOD SERUM FOR USE IN THE TREATMENT OF NEURODEGENERATIVE OPHTHALMOLOGICAL PATHOLOGIES | 2020-05-07 |
20200138861 | METHODS AND COMPOSITIONS OF NATURAL KILLER CELL ADOPTIVE TRANSFER THERAPY | 2020-05-07 |
20200138862 | ANTI-TUMOR T CELLS AND THEIR PREPARATION USING IL-6 | 2020-05-07 |
20200138863 | HEPATIC ARTERIAL INFUSION OF CAR-T CELLS | 2020-05-07 |
20200138864 | COMPOSITIONS AND METHODS OF CELLULAR IMMUNOTHERAPY | 2020-05-07 |
20200138865 | ANTI-B-CELL MATURATION ANTIGEN CHIMERIC ANTIGEN RECEPTORS WITH HUMAN DOMAINS | 2020-05-07 |
20200138866 | NON-NATURAL NKG2D RECEPTORS THAT DO NOT DIRECTLY SIGNAL THE CELLS TO WHICH THEY ARE ATTACHED | 2020-05-07 |
20200138867 | RAR SELECTIVE AGONISTS IN COMBINATION WITH IMMUNE MODULATORS FOR CANCER IMMUNOTHERAPY | 2020-05-07 |
20200138868 | Compositions for Drug Delivery and Methods of Use Thereof | 2020-05-07 |
20200138869 | GENETICALLY ENGINEERED HEMATOPOIETIC STEM CELLS AND USES THEREOF | 2020-05-07 |
20200138870 | RECREATION OF PANCREATIC NICHE ALLOWS FOR NOVEL METHODS FOR HUMAN, MATURE BETA DERIVATION FROM PLURIPOTENT STEM CELLS | 2020-05-07 |
20200138871 | SELECTION AND USE OF UMBILICAL CORD CELL FRACTIONS SUITABLE FOR TRANSPLANTATION | 2020-05-07 |
20200138872 | METHODS FOR COLLECTING AND USING PLACENTA CORD BLOOD STEM CELLS | 2020-05-07 |
20200138873 | METHODS AND COMPOSITIONS FOR IMPROVING SKELETAL MUSCLE PROTEIN FRACTIONAL SYNTHETIC RATE | 2020-05-07 |
20200138874 | COMPOSITIONS COMPRISING BACTERIAL STRAINS | 2020-05-07 |
20200138875 | AGENT FOR TREATING MICROBIOME-RELATED DISEASES | 2020-05-07 |
20200138876 | METHODS FOR MAINTAINING AND IMPROVING KIDNEY FUNCTION IN PATIENTS WITH KIDNEY DISEASE AND ON STANDARD OF CARE THERAPY | 2020-05-07 |
20200138877 | MICROBIALS FOR ANIMALS | 2020-05-07 |
20200138878 | PROBIOTIC-BASED TREATMENT OF RESISTANT CHRONIC RHINOSINUSITIS | 2020-05-07 |
20200138879 | TREATMENT OF INFANT COLIC | 2020-05-07 |
20200138880 | BACTERIA-BASED GEL COMPOSITIONS FOR TOPICAL APPLICATIONS AND USES THEREOF | 2020-05-07 |
20200138881 | NEW PROBIOTIC COMPOSITION FOR PREVENTION OF BACTERIAL VAGINOSIS | 2020-05-07 |
20200138883 | PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF GYNECOLOGICAL DISEASES CONTAINING EXTRACT OF SARCODON IMBRICATUS AS ACTIVE INGREDIENT | 2020-05-07 |
20200138884 | COMBINATION THERAPY FOR TREATMENT OF SKIN DISEASES | 2020-05-07 |
20200138885 | LIPOPHILIC ACTIVE ORAL FILM FORMULATION AND METHOD OF MAKING THE SAME | 2020-05-07 |
20200138886 | COMPOSITION, CONTAINING QUISAQUALIS INDICA EXTRACT, FOR PREVENTING OR TREATING PROSTATIC HYPERPLASIA | 2020-05-07 |
20200138887 | METHODS FOR INHIBITING CONVERSION OF CHOLINE TO TRIMETHYLAMINE (TMA) | 2020-05-07 |
20200138888 | CELASTROL AND DERIVATIVES THEREOF FOR THE TREATMENT OF TUMOURS AND PRECANCEROUS DISEASES OF THE SKIN | 2020-05-07 |
20200138889 | COMPOSITION FOR PREVENTING OR TREATING MENOPAUSAL SYNDROME, CONTAINING MEDICINAL HERB EXTRACT AS ACTIVE INGREDIENT | 2020-05-07 |
20200138891 | SOYBEAN SEED EXTRACT, METHOD FOR PRODUCING THE SAME AND USES THEREOF | 2020-05-07 |
20200138892 | ANTI-DIABETIC ACTIVITY OF NEEM EXTRACT AND SYNERGISTIC COMBINATIONS OF UROLITHINS A AND B | 2020-05-07 |
20200138893 | EXTRACT OF CITRUS RETICULATA UNRIPE FRUIT AND USES THEREOF | 2020-05-07 |
20200138894 | FLAVONOID COMPOSITIONS AND METHODS OF USE | 2020-05-07 |
20200138895 | METHODS OF TREATMENT USING DECOLORIZED ALOE VERA EXTRACTS | 2020-05-07 |
20200138896 | CURCUMIN CARBON QUANTUM DOTS AND USE THEREOF | 2020-05-07 |
20200138897 | Natural Anti-Inflammatorny Compositions and Methods of Use | 2020-05-07 |
20200138898 | METHODS FOR ATTENUATING RELEASE OF INFLAMMATORY MEDIATORS AND PEPTIDES USEFUL THEREIN | 2020-05-07 |
20200138899 | TOPICAL COMPOSITIONS COMPRISING OB-FOLD VARIANTS | 2020-05-07 |
20200138900 | ANTIMICROBIAL FUSION PEPTIDES | 2020-05-07 |
20200138901 | Antimicrobial Peptides, Their Variants and Uses | 2020-05-07 |
20200138902 | CLUSTERIN FOR USE IN THE TREATMENT OF THROMBOTIC MICROANGIOPATHIES | 2020-05-07 |
20200138903 | SOCS1-DERIVED PEPTIDE FOR USE IN CHRONIC COMPLICATIONS OF DIABETES | 2020-05-07 |
20200138904 | Methods for Generation of Cell-derived Microfilament Network | 2020-05-07 |
20200138905 | Compositions for Treating Pathological Calcification Conditions, and Methods Using Same | 2020-05-07 |
20200138906 | METHOD OF TREATING A BLADDER CANCER USING A CHIMERIC EGF-TARGETED BACTERIAL TOXIN | 2020-05-07 |
20200138907 | Composition for Use in the Treatment of an Individual Suffering a Condition Necessitating New Bone Formation | 2020-05-07 |
20200138908 | METHODS AND COMPOSITIONS FOR NATURAL KILLER CELLS | 2020-05-07 |
20200138909 | GLUCOKINASE ACTIVATOR COMPOSITIONS FOR THE TREATMENT OF DIABETES | 2020-05-07 |
20200138910 | TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY | 2020-05-07 |
20200138911 | RAPID ACTION INSULIN FORMULATIONS AND PHARMACEUTICAL DELIVERY SYSTEMS | 2020-05-07 |
20200138912 | SUPERIOR CONTROL OF BLOOD GLUCOSE IN DIABETES TREATMENT | 2020-05-07 |
20200138913 | FORMULATIONS FOR ORAL ADMINISTRATION OF ACTIVE AGENTS | 2020-05-07 |
20200138914 | ALBUMIN NANOPARTICLES FOR THE TREATMENT OF CANCER AND OCULAR DISEASES | 2020-05-07 |
20200138915 | Use of Upstream Open Reading Frame 45aa-uORF Nucleotide Sequence of PTEN Gene and Polypeptide Coded by 45aa-uORF | 2020-05-07 |
20200138916 | PROHEMOSTATIC PROTEINS FOR THE TREATMENT OF BLEEDING | 2020-05-07 |
20200138917 | PROHEMOSTATIC PROTEINS FOR THE TREATMENT OF BLEEDING | 2020-05-07 |
20200138918 | METHODS OF TREATING ABNORMALITIES OF THE FIRST METATARSOPHALANGEAL JOINT OF THE FOOT | 2020-05-07 |
20200138919 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ACUTE ISCHEMIC STROKE | 2020-05-07 |
20200138920 | Novel Combinations for Antigen Based Therapy | 2020-05-07 |
20200138921 | METHODS OF PREVENTING AND TREATING DISEASES CHARACTERIZED BY SYNAPTIC DYSFUNCTION AND NEURODEGENERATION INCLUDING ALZHEIMER'S DISEASE | 2020-05-07 |
20200138922 | HUMANIZED ANTIBODIES | 2020-05-07 |
20200138923 | PERSONALIZED VACCINE | 2020-05-07 |
20200138924 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AS TARGETS OR ACTIVE INGREDIENTS FOR USE IN IMMUNOTHERAPY AGAINST AML AND OTHER CANCERS | 2020-05-07 |
20200138925 | PROSTATE CANCER VACCINE | 2020-05-07 |
20200138926 | IMMUNITY-INDUCING AGENT | 2020-05-07 |
20200138927 | NON-CROSS-LINKED ACELLULAR PERTUSSIS ANTIGENS FOR USE IN COMBINATION VACCINES | 2020-05-07 |
20200138928 | Universal Non-Classical MHC I Vaccines: HLA-E-Restricted Antigenic Peptides as Universal Vaccines to Treat Allergy, Inflammation, Autoimmune and Infectious Diseases, and Cancers | 2020-05-07 |
20200138929 | IMMUNOGENIC PEPTIDE COMPOSITION | 2020-05-07 |
20200138930 | ATTENUATED FISH VACCINE FOLLOWING CULTURE IN IRON LIMITED MEDIA | 2020-05-07 |
20200138931 | GNA1870-Based Vesicle Vaccines for Broad Spectrum Protection Against Diseases Caused by Neisseria Meningitidis | 2020-05-07 |
20200138932 | Regimens for Immunisation With Meningococcal Conjugates | 2020-05-07 |
20200138933 | IMMUNOGENIC COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF MENINGOCOCCAL DISEASE | 2020-05-07 |
20200138934 | METHODS AND COMPOSITIONS FOR PREVENTING OR AMELIORATING PSEUDOMONAS AERUGINOSA PULMONARY INFECTIONS | 2020-05-07 |
20200138935 | CHLAMYDIA NANOEMULSION VACCINE | 2020-05-07 |
20200138936 | Phenotypically Wild-Type and Genetically Attenuated Viruses | 2020-05-07 |
20200138937 | Genetically Attenuated Nucleic Acid Vaccine | 2020-05-07 |
20200138938 | POXVIRUS VECTORS ENCODING HIV ANTIGENS, AND METHODS OF USE THEREOF | 2020-05-07 |
20200138939 | VACCINE ADJUVANT COMPOSITION BASED ON AMPHIPHILIC POLYAMINO ACID POLYMER, CONTAINING SQUALENE | 2020-05-07 |
20200138940 | STABILIZED PRE-FUSION RSV F PROTEINS | 2020-05-07 |
20200138941 | Methods and Devices for the Treatment of Food Allergies | 2020-05-07 |
20200138942 | Combination of Local and Systemic Immunomodulative Therapies for Enhanced Treatment of Cancer | 2020-05-07 |
20200138943 | Anti-IL-23 Antibodies, Compositions, Methods and Uses | 2020-05-07 |
20200138944 | MIT BIOMARKERS AND METHODS USING THE SAME | 2020-05-07 |